HYDROCODONE BITARTATE AND ACETAMINOPHEN
- Product NDC
- 51655-900
- 11-digit product format
- 516550900
- Labeler code
- 51655
- Product ID
- 51655-900_7c60a4be-adaa-edd2-e053-2991aa0a917f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- HYDROCODONE BITARTATE AND ACETAMINOPHEN
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Northwind Pharmaceuticals
- Application
- ANDA090118
- Marketing category
- ANDA
- Marketing start
- 2014-05-01
- Marketing end
- 0000-00-00
- Substance
- HYDROCODONE BITARTRATE; ACETAMINOPHEN
- Active strength
- 5 mg/1; mg/1
- Pharmacologic classes
- Opioid Agonist [EPC],Opioid Agonists [MoA]
- DEA schedule
- CII
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 51655-900-20 | 2023-12-28 | C162847 | 48780-1 | ba0f9c33-3402-a910-e053-dadaa90a0b85 | 0b32a79b-ab42-4020-9c13-064284d95258 |
| 51655-900-30 | 2023-12-28 | C162847 | 48780-1 | ba0f9c33-3402-a910-e053-dadaa90a0b85 | 0b32a79b-ab42-4020-9c13-064284d95258 |
| 51655-900-53 | 2023-12-28 | C162847 | 48780-1 | ba0f9c33-3402-a910-e053-dadaa90a0b85 | 0b32a79b-ab42-4020-9c13-064284d95258 |
| 51655-900-54 | 2023-12-28 | C162847 | 48780-1 | ba0f9c33-3402-a910-e053-dadaa90a0b85 | 0b32a79b-ab42-4020-9c13-064284d95258 |
| 51655-900-20 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-3402-a910-e053-dadaa90a0b85 | 0b32a79b-ab42-4020-9c13-064284d95258 |
| 51655-900-30 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-3402-a910-e053-dadaa90a0b85 | 0b32a79b-ab42-4020-9c13-064284d95258 |
| 51655-900-53 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-3402-a910-e053-dadaa90a0b85 | 0b32a79b-ab42-4020-9c13-064284d95258 |
| 51655-900-54 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-3402-a910-e053-dadaa90a0b85 | 0b32a79b-ab42-4020-9c13-064284d95258 |